Opzelura is under clinical development by Incyte and currently in Phase II for Unspecified Dermatological Disorders.

In short, women in midlife experience a lot of changes to their skin, and navigating the hyper-saturated skin care market can ...

Moderate-to-severe acne, or mild-to-moderate acne associated with scarring, significant psychosocial disability or failure to respond to topical therapies will require systemic therapy. This ...

A number of physical therapies are available for treating active acne, although their success is variable and some require considerable skill to perform. Glycolic acid and salicylic acid peels ...

After hours: January 8 at 5:52:10 p.m. EST ...